Leadership Overview
Zoetis has 6 executives leading key functions including technology transformation, information systems, executive operations, marketing logistics, regional finance, and international market expansion.
Focused on advancing animal health through innovation, Zoetis delivers essential medicines and diagnostic solutions to veterinarians and livestock producers globally while maintaining a commitment to scientific excellence.
Focused on advancing animal health through innovation, Zoetis delivers essential medicines and diagnostic solutions to veterinarians and livestock producers globally while maintaining a commitment to scientific excellence.
Leadership Roles at Zoetis
Lee Penn - Senior Director, Chief of Staff, Office of the Chief Executive Officer
Lee Penn, the Senior Director, Chief of Staff, Office of the Chief Executive Officer at Zoetis, coordinates strategic priorities and operational workflows for the executive leadership team. By managing the flow of critical information, Penn ensures alignment between corporate vision and departmental execution across all pharmaceutical divisions. This role involves facilitating high-level board communications and monitoring the progress of key business initiatives related to animal health medicines and vaccines. Overseeing the administrative and strategic functions of the office, the Senior Director, Chief of Staff, Office of the Chief Executive Officer drives cross-functional collaboration to achieve organizational goals. Lee Penn synthesizes complex data into actionable insights, enabling the executive team to respond effectively to shifting market demands. Through the maintenance of rigorous governance standards, the Senior Director, Chief of Staff, Office of the Chief Executive Officer supports the long-term growth and stability of the company within the global veterinary industry.
Renato Vilas Boas - Regional Chief Financial Officer, Latin America (Canada)
Renato Vilas Boas, the Regional Chief Financial Officer, Latin America (Canada) at Zoetis, directs the financial planning, reporting, and fiscal strategy for operations across the Americas. By overseeing capital allocation and budgetary controls, Boas ensures the financial health of regional business units focused on livestock and companion animal health. This role involves managing currency risks and regulatory compliance within diverse economic environments to support sustainable revenue growth. Overseeing the financial performance of regional sales and distribution networks, the Regional Chief Financial Officer, Latin America (Canada) provides critical insights that guide investment in new pharmaceutical products. Renato Vilas Boas collaborates with local leadership to optimize cost structures and improve operational margins. Through the implementation of rigorous financial oversight, the Regional Chief Financial Officer, Latin America (Canada) secures the resources necessary for expanding market reach and maintaining the company's strong financial position within the competitive veterinary medicine industry.
Stephanie Armstrong - Regional President, & Africa (Asia Pacific)
Stephanie Armstrong, the Regional President, & Africa (Asia Pacific) at Zoetis, leads the commercial strategy and operational execution for the company across diverse international markets. By driving the adoption of animal health medicines and diagnostic products, Armstrong expands the footprint of the organization within the livestock and companion animal sectors. This role involves navigating complex regulatory landscapes and building partnerships with veterinary distributors to ensure product accessibility. Overseeing the growth of regional operations, the Regional President, & Africa (Asia Pacific) aligns local market initiatives with the broader corporate mission of advancing animal wellness. Stephanie Armstrong manages cross-functional teams to deliver high-quality service to livestock producers and retail outlets. Through the strategic oversight of regional performance, the Regional President, & Africa (Asia Pacific) fosters innovation and market penetration, ensuring the company remains a trusted partner for veterinarians and animal owners throughout the expansive and high-potential regions of Africa and the Asia Pacific.
Mark Chomow - Chief Technology Officer & Head of Transformation & Portfolio Management
Mark Chomow, the Chief Technology Officer & Head of Transformation & Portfolio Management at Zoetis, directs the digital infrastructure and enterprise-wide modernization initiatives. By architecting scalable platforms, Chomow ensures the seamless integration of advanced diagnostic technologies into the broader animal health portfolio. This leadership role involves aligning technical roadmaps with long-term commercial objectives to optimize manufacturing efficiency and product development cycles. Overseeing complex transformation projects, the Chief Technology Officer & Head of Transformation & Portfolio Management drives operational agility across global research facilities. Mark Chomow maintains rigorous oversight of portfolio management, ensuring resource allocation supports high-impact pharmaceutical breakthroughs. Through the implementation of data-driven systems, the Chief Technology Officer & Head of Transformation & Portfolio Management enhances the speed at which vaccines and medicines reach veterinary markets, ultimately strengthening the competitive position of the organization within the global pharmaceutical landscape.
Michael Tao - Chief Information Officer, Greater (China, APAC)
Michael Tao, the Chief Information Officer, Greater (China, APAC) at Zoetis, manages the information technology architecture and data security frameworks across the Asia-Pacific region. By deploying robust digital solutions, Tao supports the complex supply chain requirements for livestock and companion animal products in high-growth markets. This role involves coordinating with regional leadership to ensure data integrity and system reliability for veterinary distributors and retail outlets. Overseeing the digital transformation of regional operations, the Chief Information Officer, Greater (China, APAC) facilitates real-time analytics that inform strategic decision-making for local market expansion. Michael Tao optimizes connectivity between manufacturing sites and commercial teams, ensuring consistent service delivery. Through the integration of advanced cloud-based tools, the Chief Information Officer, Greater (China, APAC) secures the technological foundation necessary for maintaining market leadership in the competitive animal health sector across the diverse and rapidly evolving Asian landscape.
Gokce Tan - Chief Marketing Officer & Logistics Coordinator
Gokce Tan, the Chief Marketing Officer & Logistics Coordinator at Zoetis, architects the global brand strategy and distribution logistics for the company's extensive range of animal health products. By aligning marketing campaigns with supply chain capabilities, Tan ensures that vaccines, dermatology treatments, and oncology products reach veterinarians and livestock producers with maximum efficiency. This role involves analyzing market trends to identify growth opportunities for companion animal and livestock segments. Overseeing the coordination of complex logistics networks, the Chief Marketing Officer & Logistics Coordinator optimizes inventory management to meet international demand. Gokce Tan drives engagement with veterinary distributors through targeted outreach and technical support programs. Through the integration of marketing intelligence and logistical precision, the Chief Marketing Officer & Logistics Coordinator enhances the visibility and availability of essential pharmaceutical solutions, directly contributing to the sustained market success and brand reputation of the organization on a global scale.
Explore Leadership Teams in Manufacturing
BeOne Medicines is a global biotechnology company focused on developing next-generation cancer treatments through innovative research and cutting-edge therapies. The company is committed to making these treatments accessible to patients worldwide, emphasizing speed, equity, and affordability in delivering care. Guided by the principle that cancer knows no borders, BeOne Medicines operates with a global perspective, striving to expand the reach of life-saving therapies and improve outcomes for patients everywhere.
Company Leadership
MD
YY
ML
SOHO Global Health is a pioneer in natural herbal-based medicine, focusing on innovative herbal research and the development of high-quality health products. Their product range includes immune boosters, children's multivitamins, and supplements aimed at improving overall health and wellness. The company is committed to harnessing Indonesia's natural resources and indigenous plants to enhance the health of its customers. SOHO Global Health aims to create positive societal impacts through strategic partnerships and a customer-centric approach.
Company Leadership RL
HS
PB
Founded in 1974, New England BioLabs is a privately held company that produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing solutions supporting genome editing, synthetic biology, and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase. The company is headquartered in Ipswitch, Massachusetts.
Company Leadership SR
LB

Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries. The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established.
Company Leadership TI
RN
FA